Xeptiva Therapeutics

  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trial
    • FAQs
  • News
    • See news
    • Press
  • Blog
  • Contact
  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trial
    • FAQs
  • News
    • See news
    • Press
  • Blog
  • Contact

ABOUT US

WE ARE​ CHANGING THE FUTURE
​OF ANIMAL HEALTH

CORE VALUES

Creativity

 Science is pure art.
Picture
​We are constantly thinking inside the box: we love making hypothesis, experimenting, building new knowledge, and thinking how to do things differently, but in the real world, with real constraints and the feet on the ground. 

Integrity

Data is king
Picture
Everything we do is tried out multiple times and backed by
data, so we make sure that our claims are solid and contribute to a world of
truthfulness, accuracy, and unbiased science

Simplicity

Do not overcomplicate things.​
Picture
We live to create simple, affordable therapies, and that translates in everything we do. Simple processes allow us to use our time wisely, be decisive and lean.

XEPTIVA AT THE GLANCE

Our company was founded in 2021, after a decade of research and development in chronic neuroinflammation, with the vision to provide a long-term solution for hard-to-manage conditions in companion animals.
R&D
10+ years of advancing R&D in neurogenic inflammation, aging and chronic conditions.
Products
5+ products in our pipeline targeting chronic diseases and inflammatory conditions associated with aging and inflammation.
Learn more
location
A USA-based biotech startup with operations in Montevideo, Uruguay.
CLINICAL STUDIES
Clinical studies are being conducted for our leading products to target chronic pain and atopic dermatitis in dogs.
learn more
Picture

XEPTIVA'S JOURNEY

Picture

COMPANY

About Us
Team

INNOVATION

Technology
Pipeline
Target diseases

clinical trial

NEWS

See News
Press releases

cONTACT

BLOG

© COPYRIGHT 2025.  ALL RIGHTS RESERVED.